Petition Ensure UK cancer patients retain access to the latest treatments after Brexit
The European Commission has made it clear it would see a post-Brexit UK as falling outside EU regulations on clinical trials and the licensing of new medications.
This could cause significant delay, or even prevent, cancer patients receiving essential life extending medications following a no-deal.
The Government should ensure that cancer patients in the UK retain access to clinical trials taking place across the EU and to any newly approved treatments.
At 10,000 signatures...
At 10,000 signatures, government will respond to this petition
At 100,000 signatures...
At 100,000 signatures, this petition will be considered for debate in Parliament